American Brain Tumor Association 2021 report cites that cancer is the second largest cause for death globally responsible for the death of approximately 8.8 million patients. World Health Organization predicts the growth of cancer incidence to reach 70% in next 20 years. Gamma knife devices faces stringent market competition by other types of radiosurgery such as Linear Accelerator Systems (LINAC) and Cyclotron. They have meritorious features in comparison to gamma knife in treating larger tumor in larger areas of brain and other body parts and precisely target only the tumor cells, causing least harm to the surrounding healthy cells.

Gamma knife devices are employed for cancer treatment by indications such as benign tumors, malignant tumors, functional disorders, vascular disorders and ocular diseases. The performance of gamma knife devices as a therapy for the indication segment is elucidated as market estimation and data forecast.

Geographical segment for gamma knife devices consists of country cross sectional market estimation and data forecast for 2019-2029.

Technological evolution in the gamma knife devices such as the radiation doses utilized, composite isocenters and automated shielding for enhanced device safety and accuracy are studied in the company profiles section. Latest merger and acquisition within the premier players are mentioned under recent news coverage. The competitive landscape gives information about the existing monopoly in gamma knife devices e.g. Elekta AB and ambitious business tactics applied by other major players to capture the market. The foremost leaders in the development of gamma knife devices for cancer treatment are Elekta AB, American Shared Hospital Services, Hokai, Cyber Medical Corporation Limited, ET Medical Group, Huiheng Medical, Inc., Masep Infini Global, Inc., Nordion, Inc. and Varian Medical Systems, Inc.

Gamma knife is a radiation surgery therapy employed for the treatment of brain tumors, epilepsy, arteriovenous malformation, and trigeminal neuralgia. The procedure consists of delivering finely focused radiation of high dose on the target cells and its high degree of precision and accuracy prohibits damage to the surrounding healthy cells. It is used for the treatment of abnormalities measuring 1 inch in diameter. Malignant tumors have a big market in the indications segment as a result of rising prevalence of patients suffering with malignant cancers. Additionally gamma knife therapy finds huge application in the treatment of malignant tumors owing to its safety features and accuracy. Fractionated external radiation therapy is considered as an adjuvant therapy for the treatment of primary brain tumor. Teletherapy a kind of gamma knife radiosurgery is finding huge attraction for the treatment of ocular diseases such as choroidal melanoma and uveal melanoma. Low radiation gamma therapy is also utilized to reduce the intraocular pressure for the treatment of glaucoma. The chief players in the global gamma knife devices market are American Shared Hospital Services, Cyber Medical Corporation Limited, ET Medical Group, Elekta AB, Hokai, Huiheng Medical, Inc., Masep Infini Global, Inc., Nordion, Inc. and Varian Medical Systems, Inc.

Center for Disease Control and Prevention 2014 survey research finding claims that every year there are approximately 1.5 million cases of invasive cancer out of which around 590,000 people die due to cancer. Rising prevalence of cancer and increasing demand for non-invasive radiation therapy drives the gamma knife devices market in North America. Western Europe is a rapidly growing market due to presence of cardinal players pioneering in manufacture of gamma knife devices. Additionally the effective cancer treatment guidelines formulated by EU have favored radiation therapy as an adjuvant therapy for the treatment of cancer that adds to the market growth in Europe.  Asia Pacific dominates the gamma knife devices market on account of rising prevalence of brain tumors, increasing specialty clinics providing effective cancer diagnosis, and treatment. Japan has invested huge in the research and development of the radiation therapy devices utilized for cancer treatment.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Gamma Knife Devices market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Gamma Knife Devices market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Gamma Knife Devices market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Gamma Knife Devices market?
• Which is the largest regional market for Gamma Knife Devices market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Gamma Knife Devices market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Gamma Knife Devices market worldwide?